MoneyGram Int (MGI:NAS) and Ophthotech (OPHT:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEA Liberty Expedia Holdings Inc 42.180000 57315762 None 0.9904 52.55 -22.37
LEXEB Liberty Expedia Holdings Inc 41.410000 57315762 None 0.9723 52.55 -22.37
SOHU Sohu.com Ltd 18.670000 38916788 None 1.0937 29.71 23.98
MGI MoneyGram International Inc 2.270000 55615351 None None 3.75 -12.48
OPHT Ophthotech Corp 2.220000 41266671 0.5376 16.8808 3.28 5.10
SCPH scPharmaceuticals Inc 4.700000 18569289 None 0.9851 5.43 4.91
ITRM Iterum Therapeutics PLC 5.740000 14159423 None 0.6857 6.00 4.97
NLNK NewLink Genetics Corp 2.080000 37224606 None 0.6336 3.28 3.28
FWP Forward Pharma A/S 1.530000 47536932 1.3421 0.8535 1.88 0.95
CAAS China Automotive Systems Inc 2.205000 31644004 None 0.2373 3.03 0.78
AQXP Aquinox Pharmaceuticals Inc 2.340000 23537368 None 0.7179 3.68 3.68
VVUS VIVUS Inc 3.650000 10629923 None None 5.46 -22.78
APWC Asia Pacific Wire & Cable Corp Ltd 2.350000 13819669 8.1034 0.2052 3.91 1.37
NVLN Novelion Therapeutics Inc 1.710000 18852557 None None 2.12 -13.42
GIGM GigaMedia Ltd 2.790000 11052235 None 0.5280 5.42 5.77
GEVO Gevo Inc 3.240000 8640433 None 0.3003 4.43 2.95
VXRT Vaxart Inc 2.640000 7141189 None 0.8434 3.35 2.72
EPIX ESSA Pharma Inc 2.914500 5776098 None 1.5390 3.13 1.93
NVIV InVivo Therapeutics Holdings Corp 1.990000 9306255 None None 2.12 2.09
MRIN Marin Software Inc 2.507700 5785000 None 0.2811 2.98 2.55
ABAC Renmin Tianli Group Inc 1.730000 8033745 21.6250 0.1560 7.82 7.56
KBSF KBS Fashion Group Ltd 4.120000 2206741 None 0.1261 10.93 10.21
ALQA Alliqua BioMedical Inc 1.670000 5005210 None 0.8760 2.22 -2.26
RSLS Reshape Lifesciences Inc 2.220000 596244 None 0.0338 3.12 1.95
RLM Realm Therapeutics PLC 2.450000 4662476 None 0.4705 3.48 2.74

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

MGI:NAS MoneyGram Int

http://www.corporate.moneygram.com
MoneyGram Int has 2936 employees and is headquartered in United States.
MoneyGram International Inc is a money transfer and payment services company. Its products include money transfers, bill payment services, money order services and official check processing.

OPHT:NAS Ophthotech

http://www.ophthotechinc.com
Ophthotech has 41 employees and is headquartered in United States.
Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate is called as Fovista.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.